Takeda Pharmaceutical Company Limited (TAK) NYSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 9.26T |
| Enterprise Value | 13.56T |
| P/E Ratio | 27.25 |
| PEG Ratio | 0.03 |
| Price/Sales Ratio | 2.27 |
| Price/Book Ratio | 1.41 |
| Enterprise/Revenue | 3.16 |
| Enterprise/EBITDA | 11.23 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.08 |
| Operating Margin | 0.13 |
AD
Management Effectiveness
| Return On Assets | 0.03 |
| Return On Equity | 0.05 |
Income Statement
| Revenue | 4.78T |
| Revenue/Share | 1,501.76 |
| Gross Profit | 2.44T |
| EBITDA | 1.38T |
| Net Income | 203.33B |
| Diluted EPS | 63.91 |
Balance Sheet
| Total Cash | 454.4B |
| Total Cash/Share | 145.4 |
| Total Debt | 4.58T |
| Total Debt/Equity | 0.62 |
| Current Ratio | 1.15 |
| Book Value Per Share | 2,373.38 |
Price History
| 52-Week Change | 49.39 |
| 52-Week High | 21.73 |
| 52-Week Low | 13.78 |
| Moving Average 50 Days | 19.24 |
| Moving Average 200 Days | 17.72 |
Statistics
| Average Volume | 2.61M |
| Shares Outstanding | 3.16B |
| % Held by Institutions | 3.36 |
Dividend And Splits
| Trailing Annual Dividend Rate | 101 |
| Trailing Annual Dividend Yield | 3.03 |
| Payout Ratio | 0.82 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
